Title : Growth hormone releaser attenuates beta-amyloid (1 - 42)-induced memory impairment in mice - Shin_2005_J.Pharmacol.Sci_99_117 |
Author(s) : Shin EJ , Jhoo JH , Nabeshima T , Jhoo WK , Kwon MS , Lim YK , Chae JS , Jung ME , Park SJ , Jang KJ , Kim HC |
Ref : J Pharmacol Sci , 99 :117 , 2005 |
Abstract :
Accumulating evidence indicates that growth hormone (GH) might be effective at preventing the development of Alzheimer's disease. However, exogenous GH treatment has exhibited side effects for clinical application; thus supplementation with amino acids to promote the release of GH could be a possible alternative treatment. In this study, mice that were fed with a diet of GH-releasing supplements had significantly attenuated memory impairments and hippocampal changes in the acetylcholinesterase activity and acetylcholine level induced by amyloid beta protein (Abeta) (1 - 42). Our results suggest that the use of GH-releasing supplement exerts beneficial effects on the memory impairment induced by Abeta (1 - 42). |
PubMedSearch : Shin_2005_J.Pharmacol.Sci_99_117 |
PubMedID: 16141634 |
Shin EJ, Jhoo JH, Nabeshima T, Jhoo WK, Kwon MS, Lim YK, Chae JS, Jung ME, Park SJ, Jang KJ, Kim HC (2005)
Growth hormone releaser attenuates beta-amyloid (1 - 42)-induced memory impairment in mice
J Pharmacol Sci
99 :117
Shin EJ, Jhoo JH, Nabeshima T, Jhoo WK, Kwon MS, Lim YK, Chae JS, Jung ME, Park SJ, Jang KJ, Kim HC (2005)
J Pharmacol Sci
99 :117